9th Annual Biomarkers Congress

Martin Oft

TypeWhite Paper Summary

At Schering-Plough Biopharma, science is driven by the excitement of linking discovery to novel drugs. As an innovative drug discovery enterprise, we are leveraging our strengths in immunology and oncology research to move important therapeutic candidates into the clinic. Backed by the powerful resources of Schering-Plough Corporation, we have the infrastructure and reach to succeed globally. Our people are the finest in the industry. Focused on the needs of the patient, they are passionate about the work they do. Together, the staff at Schering-Plough Biopharma shares one vision: to translate high quality science into new medicines and greater possibilities for humanity.

Keywords
Authors
Name:Martin Oft

Previous Comments

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.